Development of a Scalable Process for an IL-17A Inhibitor LY3509754. Part II: Synthesis of the α-Bromoketone Intermediate Leveraging Concomitant Decarboxylation Following Enzymatic Ester Hydrolysis
- 1 April 2025
- journal article
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 29 (4) , 1006-1018
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Safety Guided Process Development and Scale-Up of the Highly Energetic Compound 4-Methyl-1,2,5-oxadiazole-3-carboxylic AcidOrganic Process Research & Development, 2024
- Safety, Tolerability, and Pharmacokinetics of an Oral Small Molecule Inhibitor of IL‐17A ( LY3509754 ): A Phase I Randomized Placebo‐Controlled StudyClinical Pharmacology & Therapeutics, 2024
- Inhibition of interleukins 17A and 17F in psoriatic arthritisThe Lancet, 2020
- A Simple Synthesis of Polyfunctionalized 4‐Aminopyrazolidin‐3‐ones as ‘Aza‐deoxa’ Analogs of D‐CycloserineHelvetica Chimica Acta, 2014
- Design and synthesis of novel spirocyclopropyl cyclohexane-1,3-diones and -1,3,5-triones for their incorporation into potent HPPD inhibitorsTetrahedron Letters, 2010
- Induction of granulocyte-macrophage colony-stimulating factor by a new cytokine, ML-1 (IL-17F), via Raf I-MEK-ERK pathwayJournal of Allergy and Clinical Immunology, 2004
- Asymmetric Catalysis by Architectural and Functional Molecular Engineering: Practical Chemo- and Stereoselective Hydrogenation of KetonesAngewandte Chemie International Edition, 2001
- Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptorImmunity, 1995
- Synthetic Applications of Phosphoryl‐Stabilized Anions1977
- Recherches sur la formation et la transformation des esters LXI. Sur la réaction entre phosphite d'éthyle et les esters trifluoroacétylacétiques monochloré et monobromé, ainsi que les trifluoroacétones monochlorée et monobroméeHelvetica Chimica Acta, 1965